| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $7.0M | — | -54.4% |
| SG&A Expense | $4.7M | — | +4.3% |
| Operating Income | -$11.7M | — | +41.0% |
| Net Income | -$10.7M | — | +41.4% |
| EPS (Basic) | -$0.33 | — | +41.1% |
| EPS (Diluted) | -$0.33 | — | +41.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.6M | +4.6% | -43.4% |
| Short-term Investments | $67.9M | -13.0% | -15.0% |
| Current Assets | $107.7M | -7.5% | -26.3% |
| Total Assets | $107.8M | -7.5% | -26.3% |
| Current Liabilities | $5.3M | +3.8% | — |
| Stockholders' Equity | $102.5M | -8.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.6M | — | +40.8% |
| Investing Cash Flow | $10.2M | — | +199.3% |
| -26.3% |